Gemin X names new president/CEO

Gemin X Pharmaceuticals in Malvern appointed Glenn J. Gormley as president and chief executive.

Gormley, who has a medical degree, had held senior executive positions at Novartis, AstraZeneca and Merck Inc.

He was most recently global head of clinical development and medical affairs at Novartis.

The company specializes in the discovery and development of cancer therapeutics.